Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Update statement regarding Graham Roberts

AGR, HUM, AHT

RNS Number : 0626B
Assura PLC
14 June 2016
 

14 June 2016

 

Assura plc

 

Update statement regarding Graham Roberts

On 4 March 2016 Assura plc announced that Graham Roberts was taking a leave of absence to receive treatment for his cancer. This treatment remains ongoing and Graham now believes that he needs to focus all his energies on his further treatment and recovery, so has therefore decided to step down as CEO with immediate effect.

The Board will now commence a process to appoint a replacement CEO. As announced in March, Simon Laffin has stepped up to be Executive Chairman of Assura and will continue to do so until this process is complete.

Graham Roberts, said;

'I am very proud of what we have achieved since I became CEO of Assura in establishing the business as the leading provider of primary care property in the UK today. This is a great example of a company that has both supported local communities and created substantial value for the shareholders. We have built a first class management team and I leave the business in very capable hands. I wish them all every success in delivering the next chapter in the Assura story.'

Simon Laffin, commented;

'Graham has been a great leader and CEO to this business over the past four years, delivering a period of unparalleled success which has seen the market capitalisation increase from £152m to become a FTSE 250 company valued at over £900m. All of us are greatly saddened by Graham's illness and resignation, and wish him well. He has left a business in great shape with a fine team. We shall continue to grow Assura and support NHS primary care in the UK.'

 

- Ends -

 

For more information, please contact:

 

Assura plc

 

Tel: 01925 420660

Simon Laffin, Executive Chairman

Orla Ball, Company Secretary


 

Finsbury

 

Tel: 0207 251 3801

Gordon Simpson


 

Notes to Editors

Assura plc, a constituent of the FTSE 250, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2016, Assura's property portfolio was valued at £1,111 million.

 

Further information is available at www.assuraplc.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUOVNRNRANAAR